Diethylstilbestrol-induced cervical and vaginal adenosis using the neonatal mouse model.
The relevance of diethylstilbestrol (DES) administration to neonatal mice as a model for human pathology attributed to the use of DES in high-risk pregnancies has been investigated, particularly with respect to cervical and vaginal changes in female offspring. Neonatal DES treatment of mice results in tonic pituitary gonadotropin release and continuous estrogen secretion by the ovary. Studies were designed to determine the effect of this altered ovarian endocrine activity on cervical and vaginal histopathology. Ovariectomy of DES-treated mice, with or without estradiol replacement, did not eliminate the lesions, nor did estrogen and progesterone administered in a regimen intended to mimic estrous cycle changes. Induction of the constant estrus state by neonatal estradiol benzoate or testosterone propionate administration or by exposure to constant light did not produce the type of vaginal or cervical changes seen in DES mice. Thus, altered ovarian function is apparently not required for the vaginal and cervical changes appearing in later life. A role for endogenous (or exogenous) ovarian hormones in the developmental progression toward normality is suggested.
Prahalada
S
S
California Primate Research Center, University of California, Davis 95616.
Castracane
V D
VD
Hendrickx
A G
AG
Goldzieher
J W
JW
D000818:Animals; D000831:Animals, Newborn; D002584:Cervix Uteri / Q000187:drug effects* / Q000473:pathology; D004054:Diethylstilbestrol / Q000633:toxicity*; D005260:Female; D051379:Mice; D008807:Mice, Inbred BALB C; D010052:Ovariectomy; D014621:Vagina / Q000187:drug effects* / Q000473:pathology
D004054:Diethylstilbestrol